Recent Developments in Patent Anti-Cancer Agents Targeting the Matrix Metalloproteinases (MMPs)

E-ISSN： 2212-3970|5|2|109-141

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.5, Iss.2, 2010-06, pp. : 109-141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Developments in Anti-Cancer Agents Targeting the Ras/Raf/ MEK/ERK Pathway

Recent Patents on Anti-Cancer Drug Discovery, Vol. 4, Iss. 1, 2009-01 ,pp. : 28-35

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Developments in Anti-Cancer Agents Targeting PI3K, Akt and mTORC1/2

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 210-236

Bentham Science Publishers

Access to resources Recommend Favorite

An Updated Patent Therapeutic Agents Targeting MMPs

Recent Patents on Anti-Cancer Drug Discovery, Vol. 7, Iss. 1, 2012-01 ,pp. : 74-101

Bentham Science Publishers

Access to resources Recommend Favorite

Role of matrix metalloproteinases (MMPs) in colorectal cancer

By Zucker S.

Cancer and Metastasis Reviews, Vol. 23, Iss. 1, 2004-01 ,pp. : 101-117

Springer Publishing Company

Access to resources Recommend Favorite

Recent Developments of Steroid Sulfatase Inhibitors as Anti-Cancer Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 7, 2008-10 ,pp. : 732-738

Bentham Science Publishers

Access to resources Recommend Favorite